Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS

Abstract

Investigation of the occurrence time of adverse drug reactions helps to prevent the development and aggravation of adverse reactions, but the expression time of ganciclovir-induced adverse events has not been elucidated. In this study, using databases of spontaneous adverse event reports, the Japanese Adverse Drug Event Report database (JADER) and the U.S. Food and Drug Administration (FDA)'s Adverse Event Reporting System (FAERS), the incidence of adverse reactions due to ganciclovir and their expression time were analyzed. As a result of calculation of the reporting odds ratio (ROR) and 95% confidence interval for individual main adverse reactions of ganciclovir (cytopenia, leukopenia, thrombocytopenia, liver damage, and acute renal failure), a signal was detected for all adverse reactions in both databases, except for liver damage in JADER. Furthermore, the Weibull distribution was performed for the analysis of onset time of each ganciclovir-induced adverse event. The results of Weibull parameter α and β values of each adverse event in both JADER and FAERS suggested that most adverse events occurred within 30 d and classified into the early failure type, except that thrombocytopenia and acute renal failure in JADER classified into the random failure type. Based on these findings, it concluded that the paying attention to signs of each ganciclovirinduced adverse event is required from the early phase after ganciclovir administration. However, in FAERS, development after a long-term course also accounted for 11%, suggesting that long-term periodic monitoring of adverse reactions would be also required.

Efficacy of small‑dose ganciclovir on cytomegalovirus infections in children and its effects on liver function and miR‑UL112‑3p expression

“…However, with inhibition and control on the virus in children via small-dose ganciclovir, their liver function slowly recovers. It has been previously reported that ganciclovir may affect the liver and kidney function of patients (23). We suspected that small-dose ganciclovir would exert less effect on the liver, making it more effective in improving the liver function.…”

Comprehensive analysis of everolimus‐induced adverse events using the Japanese real‐world database

“…16 In principle, the onset time was calculated as "(onset date of adverse event) -(administration start date) +0.5". 17 The first administration date of the most recent continuous administration period was used if there was a period of non-administration for more than 1 year. The time to onset of AEs for analysis was limited to 2 years (730 days).…”

Evaluation of cardiac toxicity with ponatinib using a spontaneous reporting database

“…The time to onset was calculated for each adverse event and the number of cases was counted for reports in which the date of onset of adverse events, the date of the start of administration, and the date of the end of administration were described as year/month/day or year/month [15]. The onset time was calculated as "(onset date of adverse event) -(administration start date) + 0.5" in principle [17]. If there was a period of non-administration for more than 1 year, the date of rst administration for the most recent continuous administration period was used.…”